Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
ADILAdial Pharmaceuticals, Inc.
Filed May 16, 2022 · 10-Q · 46 days after period end · 0001213900-22-026590
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$2.91M | -$4.83M | -$2.28M | -$2.68M |
| EPS Diluted | -$0.13 | -$0.30 | -$0.22 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adial Pharmaceuticals, Inc. · CIK 1513525 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 16, 2022 · 46 d after period end
